IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer
Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested
Clinicaltrials.gov identifier:NCT07318363
Study Contact Information:
Karla Barajas, Study Coordinator [email protected]
Study specific contact information: [email protected], Phone: 713 792 9155
About the Study
The IGNITE-TX study explores ways to increase genetic testing for family members of those diagnosed with or a or genetic mutation. This is also known as cascade genetic testing.
This Study is Open To:
- People 18 years of age or older
- You or your family member has a positive genetic test result forresult for the , mutation or (, , , , mutation)
- You have an email address and/or a U.S. cell phone number
- You speak English or Spanish
This Study is NOT Open To:
- You do not have any relatives
- You do not have one of the genetic conditions listed above or only have been told you have a
What the Study Involves
If an individual is eligible for the study, they will be granted access to the IGNITE-TX website. The website contains information about their genetic mutation and how to share information with family members. Participants and their family members will be placed at random into four groups:
Group 1) Standard of care, which is receiving a letter with information on their specific syndrome that they can share with their relatives
Group 2) free genetic counseling and testing
Group 3) the IGNITE-TX intervention, which gives family members access to the website and education modules as well as access to a study navigator
Group 4) The IGNITE-TX intervention and free genetic counseling and testing.
All participants (including family members enrolled in the study) will be asked to complete a baseline survey and then follow-up surveys at 6 and 12 months. Participants will receive a $10 dollar gift card after the completion of each survey.
Learn more and self-enroll here: https://www.ignitetxstudy.com/
Study Locations
We are targeting enrollment nationwide. All participants with access to email and phone number that reside anywhere in the United States are eligible to participate and can enroll through the website.
Study PI
- J. Alejandro Rauh-Hain, University of Texas MD Anderson Cancer Center, [email protected]
- Melissa Frey, Weill Cornell Medicine, [email protected]
- Ravi Sharaf, Weill Cornell Medicine, [email protected]
Study Contact Information:
Karla Barajas, Study Coordinator [email protected]
Study specific contact information: [email protected], Phone: 713 792 9155
Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested
Clinicaltrials.gov identifier:NCT07318363
Study Contact Information:
Karla Barajas, Study Coordinator [email protected]
Study specific contact information: [email protected], Phone: 713 792 9155